ProKidney(PROK) - 2025 Q1 - Quarterly Results

Business Highlights First Quarter 2025 Financial Highlights Exhibit 99.1 ProKidney Reports First Quarter 2025 Financial Results and Business Highlights WINSTON-SALEM, N.C., May 12, 2025 – ProKidney Corp. (Nasdaq: PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today reported financial results and business highlights for the first quarter ended March 31, 2025. "The next two quarters are important for ProKidney as we ap ...